INTRODUCTION
The human diet not only supplies vital nutrients, but it also influences life span (
1) and the physiological state of many organs, as well as contributes to the development of diseases, such as obesity, type 2 diabetes (T2D), cardiovascular and inflammatory diseases, and several cancers (
2). The prevalence of nutrition-related disorders has increased in recent decades to a state where one-third of the U.S. population can be classified as suffering from metabolic syndrome (
3).
Many dietary effects on human health are mediated by the function of gut microbes. This is because a significant proportion of ingested foods escapes digestion and absorption in the small intestine and reaches the colon, a section of the gut housing a dense population of microbes. These compounds include dietary fiber, resistant starch, small amounts of simple carbohydrates, dietary proteins, and fats, as well as bile salts and enzymes released in the small intestine (
4,
5). Most of these unabsorbed compounds are fermented in the colon by the gut microbiota. For example, intestinal microbes degrade undigested polysaccharides via anaerobic fermentation to various short-chain fatty acids (SCFAs), such as butyrate, propionate, and acetate. These SCFAs are then readily absorbed and used by the colonic enterocytes as well as by cells of other tissues as a source of energy and carbon (
6). Whereas end products of carbohydrate fermentation serve positive functions in the gut, protein digestion has been shown to be detrimental to the host health due to the accumulation of harmful phenolic compounds, ammonia, and hydrogen disulfide in the colon (
5,
7). The consumption of large quantities of meat is associated with an increased risk of developing colon cancer (
8), which is possibly associated with an elevated production of the above-mentioned harmful compounds by intestinal microbiota (
9).
Much less is known about microbial degradation of dietary fats in the human gut, possibly because it was assumed that these compounds were absorbed in the small intestine (
10). However, combining the data from several reports that measured the amounts of fatty acids in the colon as well as the absorption of different fatty acids in the small intestine (
11–13), it is clear that a portion of ingested fats enters the human colon each day. Increased consumption of dietary fats on a Western diet likely saturates the ability of small intestine to emulsify and absorb all dietary lipids, thus allowing a considerable fraction to avoid absorption and reach the colon (
14). This conclusion is supported by multiple studies which showed that a high-fat diet leads to significant alterations in gut microbial communities in both humans and animals (
15,
16). For example, in mice, a high-fat diet resulted in decreased
Bifidobacterium content, which correlated with higher plasma lipopolysaccharide levels, thereby allowing the onset of inflammation, insulin resistance, and T2D associated with obesity (
17). In another study, high-fat-diet feeding of mice correlated negatively with
Akkermansia abundance but positively with the levels of
Bilophila (
18). In addition, a diet high in animal fat stimulated the growth of secondary bile acid-producing bacteria (
19), and studies have shown that secondary bile acids are cytotoxic and carcinogenic.
Despite the recognition of the detrimental gut microbiota-mediated effects of a high-fat diet on human health (
20), there is a significant gap in our understanding of which microbiota members are primarily responsible for lipid degradation and what the specific consequences of high-dietary-fat consumption on microbiota structure and functions are. To a large extent, the lack of such information can be related to the extreme difficulty of providing fat-exclusive diets to human volunteers and to rodent animal models as well. To fill these gaps, we built and validated a multivessel
in vitro human gut simulator (HGS) system and then used that system to assess the ability of the human gut microbiota to utilize dietary fats for colonization and growth.
DISCUSSION
To carry out specific perturbation experiments of human gut microbiota, we have built and validated an
in vitro multicompartmental human gut simulator system (see
Fig. 1). The general features of this system are comparable to those of other
in vitro gut simulators developed in several laboratories over the past 20 years (
21,
22,
33–35). The two main advances of our design came from the redevelopment of the nutrient medium used in the HGS to include a mix of dietary fats calculated to match what reaches the colon daily, and in the careful programming of peristaltic pumps to control the frequency and order of medium transfer among compartments. The unique advantages of such
in vitro gut systems compared to human and animal studies include (i) the ability to disentangle the effects of diet on human gut microbiota from the effects of intestinal hormonal, electrolyte, and immune system responses; (ii) the ability to sample each section of the simulated “gut” frequently over long experimental time frames without ethical constraints or animal sacrifice; (iii) complete control of the environmental conditions, sampling, and nutrient changes, which give rise to highly robust results; and (iv) measurements of actual cell counts instead of relying on relative abundance values, which helps avoid assumptions and problems associated with the use of compositional (e.g., relative abundance) data. Point iv is important because the transformation of the data into relative form leads to a constant-sum constraint, which violates the assumption of variable independence in many statistical tests and can lead to spurious correlations (
28). It is also important to recognize that such
in vitro systems are not meant to mimic the human or animal intestine completely, because they lack intestinal epithelium with all of its components (immune cells, antimicrobial peptides, surface-bound mucus layer, nutrient absorption, electrolyte exchange, etc.). While the clinical relevance of simulator studies is thus lower than that in animal and clinical works, the
in vitro gut simulators are well suited for analyses that focus on mechanisms of microbiota composition and function not directly affected by the host physiology (e.g., the effects of supplied nutrients in the diet).
The HGS system was used to carry out a 6-week-long temporal perturbation study that evaluated human gut microbiota utilization of dietary fats as the only readily available source of carbon and energy. Because such medium lacked almost all carbohydrates and proteins, this study would not be possible in human population or using common animal models. Surprisingly, the removal of carbohydrates and proteins did not lead to a drastic reduction in community cell density, as while the overall amount of energy in the environment decreased by 61%, cell density dropped only by 44%. The communities responded to the medium switch by reducing their cell size rather than numbers and by lowering their metabolic rate. Predictably, many gut microbiota members were not able to adapt to these conditions well, and we detected significant reductions in the abundances of both carbohydrate-utilizing (e.g.,
Roseburia,
Eubacterium, and
Dorea spp.) and protein-degrading (e.g.,
Bacteroides spp.) members (
36). Among the genera that decreased the most on FOM, the vast majority did not possess any fatty acid oxidation enzymes, with the exception of few species encoding a putative acyl-coenzyme A (acyl-CoA) synthetase (
Fig. 5C).
Several genera increased in abundance only once dietary fats remained in the medium, likely because they were able to utilize fats for growth and now had less competition for other nutrients. These “lipophilic” microbes included
Alistipes spp. (class
Bacteroidia) and many members of phylum
Proteobacteria, including
Bilophila,
Escherichia/
Shigella,
Citrobacter, and
Enterobacter species. The communities maintained on FOM were significantly enriched in the predicted abundances of fatty acid utilization genes, while at the same time, it was predicted that their genomes encoded far fewer carbohydrate utilization enzymes (see
Fig. 5A). With the exception of
Alistipes spp., the members of the lipophilic genera are predicted to possess the full complement of fatty acid degradation pathway genes and are thus capable of utilizing dietary fats for growth (see
Fig. 5C). It is important to point out that not every microbe that maintained its presence in the FOM-grown communities is required to degrade dietary fats. It is likely that some members, such as
Alistipes spp., relied on the metabolic cross-feeding of fermentation intermediates and end products released by the fat degraders (
37,
38).
How can dietary fatty acids be utilized by human gut microbiota? The primary mechanism of deriving energy from free fatty acids is through the cyclic β-oxidation pathway, a ubiquitous pathway used by both eukaryotic (in mitochondria) and prokaryotic (in cytoplasm) organisms. Aerobically, acetyl-CoA formed during each cycle of fatty acid degradation can generate energy efficiently by entering the tricarboxylic acid cycle and passing electrons to an electron transport chain (
39). However, under anaerobic conditions, molecular oxygen is not available to accept electrons from cytochrome oxidase, whereas cells still need to regenerate FAD and NAD
+ consumed in acyl-CoA dehydrogenase and 3-hydroxy-acyl-CoA dehydrogenase reactions of the β-oxidation pathway, respectively. This can be accomplished via anaerobic respiration with sulfate, nitrate, nitrite, or fumarate serving as terminal electron acceptors instead of oxygen (
40). In line with the higher predicted prevalence of genes encoding fatty acid β-oxidation pathway enzymes in FOM microbiota, the FOM community genomes were also predicted to be enriched in the genes coding for anaerobic terminal reductases (
Fig. 5A). The combination of β-oxidation and anaerobic respiration pathways would thus enable these bacteria to degrade free fatty acids and generate energy under anaerobic conditions.
Our findings provide mechanistic evidence for the increased prevalence of specific microbes in the guts of humans and animals fed a high-fat diet.
Table 3 demonstrates a strong concordance of our HGS-based results with the outcomes from many previous high-fat-diet intervention studies. Specifically, the majority of those studies found that
Alistipes spp.,
Bilophila spp., and total
Proteobacteria increased on high-fat diets, and we observed that members of these taxa adapted well to the FOM (see
Fig. 4F). In contrast, many high-fat-feeding reports, as well as our experiments, indicated reductions in
Bacteroides,
Clostridium, and
Eubacterium spp. and several other genera of the class
Clostridia on a high-fat diet. Finally, we showed that overall production of short-chain fatty acids is reduced on fats-only medium, also matching the majority of the findings from previous reports (
Table 3).
The relative beneficial and harmful effects of the high-carbohydrate and high-fat diets are a subject of many studies and debates (
41). While epidemiological studies show that an increase in dietary sugars and refined polysaccharides is associated with the higher prevalence of metabolic syndrome and type 2 diabetes (
42), diets rich in fiber and complex polysaccharides promote SCFA production in the gut and provide a variety of beneficial effects. On the other hand, while dietary saturated fatty acids have been linked to increased serum low-density lipoprotein cholesterol (LDL-C), the LDL-C response is highly variable, and many studies do not support a direct link between dietary saturated fat and risk of heart disease (
43). Indeed, several recent studies indicated that low-carbohydrate diets can elicit improvement in the diverse signs and symptoms of insulin resistance and its secondary manifestations, such as obesity and metabolic syndrome (
44,
45). One aspect rarely considered in the above-mentioned debate is how macronutrient composition of a diet impacts the environment of the colon and the gut microbiota residing in that region. In this study, we showed that the human gut microbiota can utilize dietary fatty acids to sustain growth. Significant changes in community composition and predicted functional capacity occurred on such a fat-exclusive diet. Such changes led to a substantial decrease in the production of SCFAs and antioxidants in the colonic region of the gut, which might have negative health consequences on the host (
46).
MATERIALS AND METHODS
Design of the gut simulator system.
The design of a three-vessel
in vitro human gut simulator (HGS) system was based on previously published models (
21,
22) and is shown in
Fig. 1. The HGS system consisted of three continuously linked fermentation vessels, each mimicking environmental conditions of the specific sections of the colon which house the majority of human gut microbes. Vessel 1 simulated the proximal colon, vessel 2 simulated the transverse colon, and vessel 3 modeled the distal colon (
21,
47). The medium (
Table 2), which closely matched food bolus contents that reach the colon (
11,
21,
48), was supplied to vessel 1, and vessel contents were moved “along the colon” in 42-ml pulses every 2 h. The medium transfer rate was set to allow an overall system retention time of 72 h to mimic the experimentally derived upper estimate of the transit time within the human colon (
49,
50). The vessel volumes were set to 500 ml, 600 ml, and 600 ml, respectively. Medium was transferred between vessels via FlexFlo peristaltic pumps (Cole Parmer, Inc.). The environmental conditions (temperature, pH, relative volume, and movement of contents) in each vessel matched those experimentally measured in the corresponding section of the human gut (
4,
50,
51). Temperature (37°C) and agitation (60 rpm) were controlled via Isotemp hot stir plates (Thermo Scientific) equipped with in-vessel temperature probes (Omega Engineering). The pH was controlled automatically using Etatron pH pumps (Cole Parmer, Inc.) and reservoir of 0.5 M NaOH. An anaerobic atmosphere was maintained through periodic daily sparging of each vessel headspace with filtered O
2-free 90%–10% mix of N
2 and CO
2 gases. Fermentation vessels were equipped with syringe adaptors, which enabled direct sampling from each vessel. A concentrated mucin solution (made from porcine gastric mucin) was supplied via syringe injection equally to all three vessels at a rate of 2 g per day.
Preparation of fecal microbiota inocula.
Fecal material was collected from three healthy male volunteers (27 to 31 years old) who had no history of antibiotic or probiotic use, and no gastrointestinal illness for 6 months immediately preceding the fecal collection. All fecal samples were mixed together and thoroughly homogenized to ensure that all inocula contained equivalent microbial populations. All fecal processing was performed on ice under N2 atmosphere. Fecal slurries were prepared at 10% (wt/vol) in chilled anaerobic phosphate-buffered saline (PBS) and frozen.
Operation of human gut simulator.
Two media were used to supply nutrients to microbial communities in the proximal vessel. The balanced Western medium was a rich medium containing carbohydrates, fats, and proteins in proportions matching the expected macronutrient distribution in colon influent on an average Western diet (55%, 20%, and 25%, respectively; see
Table 2). The second medium (denoted fats-only medium [FOM]) was depleted in carbohydrates and proteins while maintaining the same level of dietary fatty acids (11%, 71%, and 18% of carbs, fats, and proteins, respectively). Resazurin was added to both media as an anaerobic indicator. All HGS vessels were seeded with a 50-ml aliquot of 10% fecal slurry and were incubated for 12 h to allow community establishment. The proximal vessel of the HGS system was then supplied semicontinuously (pulse every 2 h) with the Western medium (WM) for 14 days to allow community stabilization. At the end of day 14, the Western medium was replaced with the fats-only medium and the HGS system was operated for a further 28 days. Two completely independent 42-day-long runs were performed. In addition, a single control run was carried out where after 2 weeks on Western medium, the system was supplied with a medium containing only yeast extract and salts (denoted yeast extract medium [YEM]). To obtain cell density counts (in cells per milliliter) of each community, HGS samples collected from each vessel were diluted 100-fold, and cells were enumerated on Spencer hemacytometer via phase-contrast microscopy.
Anaerobic batch culturing.
Ten-milliliter aliquots of WM, FOM, and YEM were first equilibrated for 24 h in an anaerobic atmosphere (85% N2, 10% CO2, and 5% H2) inside the Coy anaerobic chamber. Cultures were then inoculated with fecal microbial inoculum identical to those used for HGS runs. All batch cultures were incubated inside the anaerobic chamber for 72 h to match the HGS transit time. Cell counting was performed as described above. Two replicate batch cultures were carried out for each type of medium.
Bomb calorimetry.
A Parr 6200 isoperibol calorimeter (Parr Instrument Co.) was used to carry out isoperibol bomb calorimetry in order to determine the gross energy of growth media. Prepared aliquots of each medium were lyophilized, packed into capsules, weighed, and then combusted in the isoperibol bomb. Measurements were done in triplicate and calibrated to the energy of glycolic acid, and the capsule energy was subtracted from the total energy values obtained.
Isolation of nucleic acids and high-throughput DNA sequencing.
Total nucleic acids were extracted following the hot phenol-chloroform method and incorporated a bead-beating step to break down microbial cells (
27). Total RNA and DNA were quantified on Qubit 2.0 fluorometer using Qubit RNA BR and Promega Qubit double-stranded DNA (dsDNA) HS assay kits, respectively, according to the manufacturer's protocols. Community metabolic activity was defined as the ratio of total RNA to DNA based on previous studies showing an association between this measure and population metabolic activity (
52,
53).
Bacterial genomic DNA was isolated from each HGS sample using the ZR fungal/bacterial DNA MiniPrep kit (Zymo Research), as we did previously (
27). Genomic DNA (gDNA) was amplified using two pairs of primers, one targeting 16S rRNA gene V1–V2 region (forward primer 16S gene complementary sequence, AGRGTTYGATYMTGGCTCAG; reverse primer 16S gene complementary sequence, GCWGCCWCCCGTAGGWGT), and another targeting V4 region (forward [GCCAGCMGCCGCGG] and reverse [GGACTACHVGGGTWTCTAAT] complementary sequences, respectively). Two different regions were interrogated to reduce biases in community composition estimates associated with the use of any one region of the 16S rRNA gene (
26). Forward primers contained an Ion Torrent P1 adapter sequence, 6- to 7-nucleotide barcode sequence, and variable region-specific sequence. Reverse primer sequences included the adapter A and variable region-specific sequence. PCR amplification was performed with 25 ng of starting gDNA material and included 10 cycles of linear elongation with only the forward primers used, followed by 25 cycles of traditional exponential PCR (
54). The inclusion of a linear PCR step decreased the stochasticity of the first few PCR steps (
27) and allowed the use of a single PCR amplification reaction per sample. Purified amplicons were pooled equimolarly, and sequencing libraries were prepared using the Ion PGM template OT2 400 kit (Life Technologies, Inc.), according to the manufacturer's protocol. High-throughput sequencing was performed on an Ion Torrent PGM using the Ion PGM sequencing 400 kit and Ion 316 Chip. We obtained an average of 40,129 sequence reads per sample. Sequence reads were processed in QIIME (
55). For each sample, sequence reads for different 16S rRNA gene variable regions were subsampled to the lowest value and then merged. Annotation of operational taxonomic units (OTUs) was performed via an open reference method against the Ribosome Database Project reference database version 11 of 16S rRNA sequences. Any sequences with below 60% annotation confidence were labeled “unassigned” at that taxonomical level. To obtain cell counts, sequence read counts for each OTU were first adjusted by dividing them by a known or predicted number of 16S rRNA gene copies in that organism's genome, following a previously described approach (
27). Incorporating 16S rRNA gene copy number information was shown previously to improve estimates of microbial diversity and abundance (
56). For the OTUs annotated above the species level, an average of 16S rRNA gene copies in all organisms of the next taxonomical level (e.g., genus, and if no data for that genus, a family) was used to calculate an estimated 16S rRNA gene copy number. These 16S rRNA gene copy-adjusted read counts were then converted to sample-specific cell counts based on the previously determined cell density measurements for each sample. As a result, the sum of cells of all taxa within each sample equaled the cell density in that sample, so that a sample with higher cell density had a proportionally higher overall number of cell counts. This approach allowed us to estimate the actual cell counts for each taxon in every sample and not rely on the relative abundance values (
28).
Terminal restriction fragment length polymorphism.
Terminal restriction fragment length polymorphism (TRFLP) analysis was used to assess the stability of microbial communities during HGS validation experiments. Full-length 16S rRNA gene was amplified in a PCR, as described previously (
27). Bact-27F and Univ-1492R primers were fluorescently labeled with 6-carboxyfluorescein (6-FAM) and 5-HEX fluorophores, respectively. Following amplification, three reaction mixtures were pooled and subjected to restriction endonuclease digestion by HaeIII and RsaI enzymes (New England BioLabs) at 37°C for 4 h. Restriction digests were prepared for genotyping by mixing 40 ng of digested sample with 8 μl of formamide. Samples were run on a 3730x capillary sequencer employing ROX500 internal standard for fragment size determination. Raw TRFLP profiles were annotated against the internal standards using the PeakScanner version 1.0 software and were further processed in Microsoft Excel utilizing custom-designed Visual Basic scripts. The scripts removed the ladder fragments and nonessential labels, reformatted character strings, and calculated sum of the peak areas/heights. Fragment peaks contributing less than 0.4% of the overall profile area were discarded.
Metabolite profiling.
Collected samples were centrifuged and supernatants filtered to remove particles. Twenty microliters of each supernatant were injected onto an Aquasil C18 reverse-phase column attached to the HPLC system (Thermo Scientific). The mobile phase was 50 mM phosphate buffer and acetonitrile (99:1 ratio) at pH 2.8. Short-chain fatty acids were eluted at a flow rate of 1.25 ml · min−1 over a 30-min period and detected at a 210 nm wavelength. Standard curves were constructed for each acid over a range of 100 mM to 10 μM concentrations.
Antioxidant capacity in samples was estimated by measuring supernatant ability to neutralize and counteract oxidation by ABTS [2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)] radical. The supernatant was diluted 20-fold and mixed with a fresh 1:1 solution of 7 mM ABTS and 2.45 mM potassium persulfate. The reaction was measured colorimetrically at a 730 nm wavelength in triplicate. Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) was used as a standard to create daily calibration curves for the ABTS-potassium persulfate solution. Antioxidant capacity was expressed as micromoles per milliliter of Trolox.
Bacterial cell size comparison.
Bacterial cells were pelleted by centrifugation at 14,000 × g for 5 min. The supernatant was discarded, and the pellet was washed twice with 1 ml of isotonic Tris-buffered saline (TBS). The final pellet was diluted with TBS to an approximate cell concentration of 1 × 106 cells · ml−1 based on the cell density measurements of the cultures. Cells were then labeled with SYTO9 fluorescent dye and analyzed on an Accuri C6 flow cytometer, with 66 μl · min−1 flow rate, detection threshold of 1,000 relative fluorescence units, and 22-μm core size. The distribution of cell sizes was estimated from the forward-scatter values of all SYTO9-positive events.
Statistical analyses.
Repeated-measures analysis of variance (ANOVA) was used to test the statistical significance of the differences in measured values between WM and FOM time points. Multivariate statistical analyses (principal-coordinate analysis, canonical correspondence analysis, and principal response curves) were performed on the genus-level microbial abundance data set generally following the approaches we described previously (
28). Matlab- and R-based scripts were used to run all algorithms. Statistical significance of group separation in principal-coordinate analysis space was calculated based on the permutation analysis of the Davies-Bouldin index, as we did previously (
57). Weighted UniFrac distance-based principal response curves (dbPRC) analysis was performed as described previously (
29). This method used phylogenetic UniFrac distance as a measure of sample dissimilarity and carried out a partial redundancy analysis to isolate the part of the total data set variance attributable to sample collection time as a variable (see reference
28) for a more detailed explanation. dbPRC is especially suited to analyze time-series data sets (
29).
Accession number(s).
The sequence data set is available in the Sequence Read Archive repository under BioProject
PRJNA487598.
ACKNOWLEDGMENTS
We are thankful to Vijay Shankar, Michael Bottomley, and Daniel Organisciak for valuable comments, and to Lynn Hartzler for access to a bomb calorimeter.
Parts of this work were supported by Dayton Area Graduate Studies Institute award RH15-WSU-15-1 to R.A., A.G., and O.P., by National Science Foundation award DBI-1335772 to O.P., and by award AGL2014-53895-R from the Spanish Ministry of Economy and Competitiveness and by the European Regional Development Fund (FEDER) to S.P.-B. and J.A.R.-H.
R.A. and O.P. conceived the study; R.A., A.G., D.L.K., and S.P.-B. carried out all experiments; and O.P., J.A.R.-H., and R.A. wrote the manuscript.